These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21145968)
1. Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact. Talmadge JE Semin Cancer Biol; 2011 Apr; 21(2):131-8. PubMed ID: 21145968 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Talmadge JE; Donkor M; Scholar E Cancer Metastasis Rev; 2007 Dec; 26(3-4):373-400. PubMed ID: 17717638 [TBL] [Abstract][Full Text] [Related]
3. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718 [TBL] [Abstract][Full Text] [Related]
4. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [TBL] [Abstract][Full Text] [Related]
5. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488 [TBL] [Abstract][Full Text] [Related]
7. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma. Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944 [TBL] [Abstract][Full Text] [Related]
9. Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Solheim JC; Reber AJ; Ashour AE; Robinson S; Futakuchi M; Kurz SG; Hood K; Fields RR; Shafer LR; Cornell D; Sutjipto S; Zurawski S; LaFace DM; Singh RK; Talmadge JE Cancer Gene Ther; 2007 Apr; 14(4):364-71. PubMed ID: 17235356 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962 [TBL] [Abstract][Full Text] [Related]
11. Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 2000; 20(3A):1759-68. PubMed ID: 10928105 [TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Barnett JC; Bean SM; Whitaker RS; Kondoh E; Baba T; Fujii S; Marks JR; Dressman HK; Murphy SK; Berchuck A Gynecol Oncol; 2010 Mar; 116(3):556-62. PubMed ID: 20006900 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Clark CE; Hingorani SR; Mick R; Combs C; Tuveson DA; Vonderheide RH Cancer Res; 2007 Oct; 67(19):9518-27. PubMed ID: 17909062 [TBL] [Abstract][Full Text] [Related]
14. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells. Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832 [TBL] [Abstract][Full Text] [Related]
15. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy. Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446 [TBL] [Abstract][Full Text] [Related]
16. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239 [TBL] [Abstract][Full Text] [Related]
17. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance. Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840 [TBL] [Abstract][Full Text] [Related]
18. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines. Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196 [TBL] [Abstract][Full Text] [Related]
19. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174 [TBL] [Abstract][Full Text] [Related]
20. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12. Mortarini R; Borri A; Tragni G; Bersani I; Vegetti C; Bajetta E; Pilotti S; Cerundolo V; Anichini A Cancer Res; 2000 Jul; 60(13):3559-68. PubMed ID: 10910069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]